La demande pour des médicaments amaigrissants non homologués comme Ozempic comporte des risques pour la santé d’une perte de poids non supervisée et le développement de troubles de l’alimentation.
- PhD Candidate, Clinical Psychology, Western University
The demand for off-label weight loss drugs like Ozempic is concerning, because of the impact on weight stigma and the health risks of unsupervised weight loss, including developing eating disorders.
Contact Samantha for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Location: London, Canada
- X (formerly Twitter): @sjwithnell
- Article Feed
- Joined
